layout.fixed.naaccr.doc.naaccr12.rxTextBrm.html Maven / Gradle / Ivy

Show more of this group Show more artifacts with this name
Show all versions of layout Show documentation

Framework that allows defining file formats (layouts) and use them to read and write data files.

There is a newer version: 5.5


    
        Alternate Name
        Item#
        Length
        Source of Standard
        Column #
    
    
        
        2660
        1000
        NPCR
        17765-18764
    



Description

Text area for manual documentation of information regarding the treatment of the tumor being reported with biological response modifiers or immunotherapy.



Rationale

Text documentation is an essential component of a complete electronic abstract and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.



The text field must contain a description that has been entered by the abstractor independently from the code(s). If cancer abstraction software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record and should not be generated electronically from coded values.



Instructions

Prioritize entered information in the order of the fields listed below.
Text automatically generated from coded data is not acceptable.
NAACCR-approved abbreviations should be utilized (see Appendix G).
Do not repeat information from other text fields.
Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.
If information is missing from the record, state that it is missing.
Do not include irrelevant information.
Do not include information that the registry is not authorized to collect.




Note: For abstracting software that allows unlimited text, NAACCR recommends that the software indicate to the abstractor the portion of the text that will be transmitted to the central registry.



Suggestions for text:

Date treatment began
Where treatment was given, e.g., at this facility, at another facility 
Type of BRM agent, e.g., Interferon, BCG
BRM procedures, e.g., bone marrow transplant, stem cell transplant
Other treatment information, e.g., treatment cycle incomplete; unknown if BRM was given



Data Item(s) to be verified/validated using the text entered in this field

After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields:

    
        
        Item name
        Item number
    
    
        
        Date of Initial RX--SEER
        1260
    
    
        
        Date of 1st Crs RX--CoC
        1270
    
    
        
        RX Hosp--BRM
        720
    
    
        
        RX Date Systemic
        3230
    
    
        
        RX Summ--Tranplnt/Endocr
        3250
    
    
        
        RX Summ--BRM
        1410
    
    
        
        RX Date--BRM
        1240
    
    
        
        RX Summ--Systemic/Sur Seq
        1639

	Item name	Item number
	Date of Initial RX--SEER	1260
	Date of 1st Crs RX--CoC	1270
	RX Hosp--BRM	720
	RX Date Systemic	3230
	RX Summ--Tranplnt/Endocr	3250
	RX Summ--BRM	1410
	RX Date--BRM	1240
	RX Summ--Systemic/Sur Seq	1639